Original Research

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

Svedbom A, Dalén J, Black CM, Kachroo S

Patient Preference and Adherence 2017, 11:95-106

Published Date: 16 January 2017